Mar 31, 2021

Entrada Therapeutics Q1 2021 Earnings Report

EPS
-$6.67
Previous year: -$5.18
+28.7%
Cash and Equivalents
$146M
Free Cash Flow
-$9.24M

Entrada Therapeutics

Entrada Therapeutics